HL Launches Telepharmacy Platform to Boost Revenue to New Record This Year

Product / Tech
โดย Share2Trade·US·Read original
Summary · why it matters

Healthlead (HL) is set to launch its application service platform operated by iCare Health Company in the near future, in response to the Telepharmacy trend, following FDA approval for patients to legally consult pharmacists and receive medications at home. With logistics partner CERO Win enhancing delivery standards, this marks a significant step in integrating technology with the Health & Wellness business, increasing access to pharmaceutical services, and opening doors to new business opportunities in the future. The platform is expected to serve as a growth engine, supporting long-term expansion and driving this year's revenue to a new record high as planned.

Impact on stocks 1

Health Care · 1 stocks
Healthlead Public Company Limited
HL
▲ PositiveTechnologyDemandrelevance

HL launches its iCare-operated telepharmacy platform following FDA approval for legal remote pharmacist consultations and home medication delivery.

Off-coverage companies 1

CERO WinPrivate▲ Positive
Demandrelevance

CERO Win is named as HL's logistics partner enhancing delivery standards for the telepharmacy platform.